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ing of the state health care system, and the society experi-
encing socioeconomic hardships.
METHODS: In 222 verified mild to moderate EH (mean
age 49.4  0.9 years) as well as in 77 age-, gender-, body
mass- and social status-matched healthies (H) the QL as-
sessment was performed using the well-validated, self-
administered questionnaires: The Giessen Somatic Com-
plaints Questionnaire (GSC) and The General Well-Being
Adjustment Scale (GWB).
RESULTS: The QL tests revealed significantly lower QL
scores on all GSC and GWB subscales in the investigated
Belarusian EH compared with H (Gastric Complaints,
Pains, Cardiac Complaints, Exhaustion, Anxiety, Depres-
sion, Well-Being, Self-Control, General Health, Vitality)
with the total Complaints Index (mean  SEM) 52.4  2.6
vs. 22.5  1.9 points (p  0.001), and the total GWB in-
dex 78.6  1.3 vs. 94.5  2.1 points (p  0.01), respec-
tively. QL scores did not correlate (Spearman) with office
blood pressure and age. Females demonstrated less favor-
able scores on all subscales compared with males in both
groups (Mann-Whitney, p  0.01). Educational level, oc-
cupation, physical activity had no impact on the QL
(ANOVA). There was an association of the total QL with
alcohol and coffee consumption as well as smoking (stan-
dardized interview), while abstinents had the lowest QL
scores (p  0.05). The QL total indexes were significantly
(p  0.05) worse in the EH treated on regular basis com-
pared with EH who did not treat their known hyperten-
sion. The high QL score, smoking, drinking and male gen-
der were revealed as factors of poor compliance with
previous routine medical care.
CONCLUSIONS: Gender and certain life-style factors in-
fluence the QL profile of EH living in Belarus and relate to
compliance, this requiring careful consideration during hy-
pertension management.
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OBJECTIVES: A rigorous translation methodology is es-
sential in order to develop equivalent language versions of
health-related quality of life questionnaires for use in clini-
cal research and trials. Using differential item functioning
(DIF) within the item response theory framework to aug-
ment traditional reliability analysis provides additional evi-
dence to evaluate whether the translated versions are psy-
chometrically equivalent.
METHODS: The Functional Assessment of Chronic Illness
Therapy (FACIT) Measurement System translation meth-
odology consists of 2 forward translations, 1 reconciled
version, a back-translation of the reconciled version, and 3
independent reviews by bilingual experts. The translated
versions are then pretested with at least 15 patients in the
respective native countries. In this presentation, we focus
on five translated versions of the FACT-G (Hungarian, Jap-
anese, Polish, Portuguese, and Russian) that were each
tested with at least 40 patients and analyzed; the total sam-
ple was 316 oncology patients. The internal consistency of
the 27-item core FACT-G was evaluated using Cronbach’s
alpha. Rasch analysis was used to determine the item diffi-
culty hierarchy of each language version, and then DIF
analysis was used to determine psychometric equivalence in
relation to the English version (n  131).
RESULTS: The 27 core FACT-G items included in every
FACIT measure showed high reliability in these five lan-
guage versions, with Cronbach’s alpha ranging from .87
(Japanese) to .93 (Polish). Items exhibiting potential DIF
and their possible causes were summarized.
CONCLUSION: Reliability and DIF analyses confirm that
the five translated versions are psychometrically valid and
comparable. The FACIT translation methodology has been
effective in adapting a North American questionnaire to
vastly different cultural contexts and creating valid versions
for cross-cultural comparisons. Further research and devel-
opment of new language versions is needed, especially in
non-Western European languages to extend QoL research
possibilities internationally.
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OBJECTIVES: The use of antipsychotics in the treatment
of schizophrenia has changed patient connections to their
surroundings, placing them in greater contact with their
family and the environment in which they carry out daily
activities. The purpose of this analysis of patients in the
naturalistic setting was to evaluate the changes in health
related quality of life (HRQL) associated with antipsy-
chotic drug therapy and to evaluate the sensitivity of the
Euroqol-5D (EQ-5D) as a tool for measuring HRQL in
patients with schizophrenia.
METHODS: The study included 2,128 patients with
schizophrenia who were treated with olanzapine, 821 who
were treated with risperidone or haloperidol, and small
numbers of patients on other antipsychotics. Sociodemo-
graphic, clinical (global clinical impression, global activity
evaluation scale, presence of extrapyramidal symptoms)
and the EQ-5D as a generic tool for the measurement of
the HRQL were included as variables. The patients were
evaluated at treatment initiation and after 6 months.
RESULTS: Olanzapine-treated patients showed the larg-
est effect size on the Visual Analog Scale (VAS) (0.98)
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and the EQ-5D Index (EQ-I) (1.13) compared with the
remaining antipsychotic drugs (0.58-0.75 for the VAS
and 0.78-0.96 for the EQ-I). The olanzapine-treated
group had the highest proportion of patients with an im-
provement, particularly in the daily activities and mood
domains, and the lowest proportion of patients who
worsened after 6 months of treatment.
CONCLUSION: Treatment with antipsychotic drugs, es-
pecially olanzapine, improves the HRQL of patients with
schizophrenia. The study also indicates that the EQ-5D is
useful and sensitive tool for detecting changes in the
health of patients with schizophrenia.
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OBJECTIVES: To improve the evaluative-scale character-
istics of the WHQ. Comparative clinical trials require eval-
uative scales that are sensitive and responsive as well as
valid and reliable. The Women’s Health Questionnaire
(WHQ), a 36-item, 4-point Likert self-administered rating
scale, assesses subjective reports of emotional and physical
well-being in mid-aged women using nine physical, emo-
tional, and symptom-specific scales. We assessed the
WHQ evaluative scale properties using both true score and
Rasch measurement models to determine whether the
scoring techniques proposed by the scale developer opti-
mized the evaluative properties.
METHODS: We analyzed WHQ baseline and six-week
change score data from 651 mid-aged women treated
with HRT in two US clinical trials. The Multitrait/Multi-
item Analysis Program—Revised provided true score psy-
chometric information. The BIGSTEPS program pro-
duced the Rasch analysis.
RESULTS: The original nine-factor structure was not sup-
ported by confirmatory factor analysis. Rasch analysis
identified scale-level category response problems for sev-
eral scales in the revised six-factor structure. The problem-
atic scales failed to detect differences between “known
groups” formed by clinical criteria for menopausal symp-
toms, and were not responsive to change within groups
that changed significantly on clinical criteria. Revised scale
scoring based on Rasch conversion to standardized logits
resulted in improved sensitivity and responsiveness.
CONCLUSIONS: Rasch models provide important psy-
chometric information for scale development and revi-
sion. They resolve interval data assumptions, are more
sensitive to information contained in the tails of the re-
sponse distributions, and yield useful response category
analyses that guide scaling decisions independent of the
sample characteristics. Based on the Rasch analysis, we
made scoring and interpretation changes to the WHQ
that increased its sensitivity and responsiveness.
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OBJECTIVES: Measurements of the patient health status
should be simple and concise in clinical practice. The
Asthma Bother Profile (ABP), which consists of 23 items,
has been developed to assess how much asthma bothers pa-
tients. The Airway Questionnaire 20 (AQ20) is a simple in-
strument which consists of 20 items regarding the health
status of asthma and COPD patients. The purpose of this
study was to investigate how the ABP and AQ20 evaluate
the health status of patients with asthma, and to examine
the relationships between these two measures and clinical
parameters, generic and asthma-specific instruments.
METHODS: A total of 193 patients with chronic asthma
(age: 48  8 yr, 95 males) completed a pulmonary function
testing, a measurement of airway hyperresponsiveness, the
dyspnea rating (MRC; Medical Research Council dyspnea
scale), and assessments of the anxiety and depression
(HADS; Hospital Anxiety and Depression Scale), and as-
sessments of their health status. The health status was as-
sessed using the ABP, AQ20, SF-36, Living with Asthma
Questionnaire (LWAQ) and the Asthma Quality of Life
Questionnaire (AQLQ). The Japanese version of the ABP
included only 15 items out of the original 23 items due to
cultural differences.
RESULTS: The score distributions on the ABP and AQ20
were skewed towards the mild end of the scale (median
score [interquartile range]: 2 [1–4] and 13 [6–22], respec-
tively). Moderate correlations were noted between the
Anxiety on the HADS and the ABP and AQ20 scores
(Spearman’s rank correlation coefficient [Rs]  0.44 and
0.62 respectively). The ABP had a strong correlation with
the LWAQ (Rs  0.81), and its strongest correlation
with the General Health (Rs  0.64) among the 8 sub-
scales on the SF-36. The AQ20 had a moderate correlation
with the LWAQ (Rs  0.61). The FEV1, peak expiratory
flow rates, degree of airway hyperresponsiveness and treat-
ment steps of asthma showed mild correlations with the
ABP and AQ20 (Rs  0.20  0.26).
CONCLUSIONS: The ABP and AQ20 were short and
simple to complete, and both measures could easily be used
in clinical practice. The ABP can evaluate patients more
specifically with respect to the distress and bother induced
by asthma than the AQ20.
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